| G A S TRI C EMP T YING AND DYS PEPS IA
Ginger as an important dietary agent which possesses carminative effect, decreases pressure on lower esophageal sphincter, reduces intestinal cramping, and prevents dyspepsia, flatulence, and bloating (Ali et al., 2008; Chrubasik, Pittler, & Roufogalis, 2005; Lohsiriwat, Rukkiat, Chaikomin, & Leelakusolvong, 2010) . A clinical trial investigated the effects of ginger extract (100 mg, corresponding to 2 g of rhizome twice a day) on gastrointestinal motility and showed a significant increase in gastrointestinal motility in the intervention group in comparison with the placebo (Micklefield et al., 1999) . Wu et al. (2008) showed that ginger accelerates gastric emptying and stimulates antral contractions in healthy individuals; studies on patients with functional dyspepsia have shown the same results with no alterations in the fundus dimension, gastrointestinal symptoms, or serum level of gut peptides such as GLP-1, motilin, and ghrelin (Hu et al., 2011) .
Impaired gastric emptying is a well-recognized contributor to the pathophysiology of gastrointestinal problems such as functional dyspepsia and nausea. Functional dyspepsia is defined as postprandial fullness, early satiety, or epigastric pain/burning or discomfort centered in the upper abdomen in the absence of any known structural cause and without features of irritable bowel syndrome or gastroesophageal reflux; symptoms are frequently correlated to meals and may include abdominal pain, bloating, early satiety, fullness, belching, and nausea (Talley et al., 1999) .
Prodigest is the standardized combination of ginger extracts and artichoke extract. Artichoke completes the effects of ginger because ginger is active on stomach while artichoke on small bowel. A randomized, 4-week trial on patients with functional dyspepsia showed that daily consumption of Prodigest before lunch and dinner resulted in a significant amelioration of functional dyspepsia symptoms including nausea, epigastric fullness, epigastric pain, and bloating as compared with placebo (Giacosa, Guido, et al., 2015) . A randomized crossover study investigated the effects of Prodigest on gastric emptying in 11 healthy volunteers. In this study, the baseline area of gastric volume was determined by ultrasonography 10 min before the main meal.
Then, the subjects were given one Prodigest or placebo capsule and consumed a standardized meal. One hour after the meal, the gastric volume was measured again. The gastric emptying was compared by differences between gastric volumes. Finally, the results indicated that the after-meal gastric area was significantly smaller, with a −24% difference, following the combination of extracts, as compared with placebo. So, Prodigest significantly promotes gastric emptying in healthy volunteers without being associated with notable adverse effects (Lazzini, Polinelli, Riva, Morazzoni, & Bombardelli, 2016) . These effects [6]-shogaol do modulate all these receptors (Giacosa, Guido, et al., 2015; Lazzini et al., 2016) .
Delayed gastric emptying leads to gastric intolerance to gavages and increases gastric residual volume, vomiting, risk of aspiration, and the length of stay in hospital in 30-51% of the patients (Davies, 2010; Landzinski, Kiser, Fish, Wischmeyer, & MacLaren, 2008) .
Delayed gastric emptying and gastrointestinal motility disorder are the main gastrointestinal problem in the severely ill patients undergoing mechanical ventilation. A double-blind randomized controlled clinical trial showed that consumption of 120 mg ginger extract for 4 days significantly lowered mean residual volume of feeding with a standard gavage solution, on the fifth and the sixth days of feeding (Ghochae et al., 2013) . Another study also showed that ginger extract increases the amount of tolerated food, and the amount of calorie intake in patients with adults respiratory distress syndrome under mechanical ventilation (Shariatpanahi, Taleban, Mokhtari, & Shahbazi, 2010) .
| NAUS E A AND VOMITING
The most common cause of nausea and vomiting is pregnancy. Nausea and vomiting affect up to 80% of women during the first trimester of pregnancy that range from morning sickness to hyperemesis gravidarum (HG) (Lete & Allué, 2016; McCarthy, Lutomski, & Greene, 2014; Palatty, Haniadka, Valder, Arora, & Baliga, 2013) . Nonpharmacologic management of nausea in pregnancy includes avoiding nausea-inducing foods and eating small, frequent meals (Matthews, Dowswell, Haas, & O'Mathúna, 2010 ).
Administration of pyridoxine or doxylamine-pyridoxine might be beneficial. Medications such as dimenhydrinate, promethazine, ondansetron, or chlorpromazine can be used in severe cases, while 250 mg of ginger taken orally every 6 hr might be added at any time (Arsenault et al., 2002) . The impact of ginger consumption as an antiemetic in nausea and vomiting of pregnancy has been extensively investigated in clinical studies for at least 30 years . The studies have shown that ginger in dose of 1 g/day is effective in pregnancy nausea and vomiting with no significant side effects (Firouzbakht, Nikpour, Jamali, & Omidvar, 2014; Haji Seid Javadi, Salehi, & Mashrabi, 2013; Saberi, Sadat, Abedzadeh-Kalahroudi, & Taebi, 2014; Thomson, Corbin, & Leung, 2014; Viljoen, Visser, Koen, & Musekiwa, 2014) . American College of Obstetricians and Gynecologists (ACOG), and the National Institute for Health and Clinical Excellence, has accepted ginger as a remedy for nausea and vomiting during early pregnancy (Table 1) .
Another disturbing cause of nausea and vomiting is the side effects of chemotherapy (Ryan, 2010) . Some chemotherapeutic agents, including cyclophosphamide and cisplatin, can lead to a high incidence of nausea and vomiting (Herrstedt & Dombernowsky, 2007) . The standard of care for chemotherapy-induced vomiting is antiemetics, most notably serotonin (5-HT3) receptor antagonists and glucocorticoids, such as dexamethasone; however, efforts to control nausea have not been successful (Bloechl-Daum, Deuson, Mavros, Hansen, & Herrstedt, 2006; Herrstedt & Roila, 2008) . The summary of studies evaluating the effects of ginger consumption on chemotherapy-related nausea and vomiting is shown in Table 2 ( Ansari et al., 2016; Arslan & Ozdemir, 2015; Fahimi et al., 2011; Manusirivithaya et al., 2004; Marx et al., 2013; Panahi et al., 2012; Pillai, Sharma, Gupta, & Bakhshi, 2011; Ryan et al., 2012; Sanaati, Najafi, Kashaninia, & Sadeghi, 2016; Sontakke, Thawani, & Naik, 2003; Thamlikitkul et al., 2017; Zick et al., 2009 ). Nausea and vomiting can occur after surgery, medications, or even exercise. Despite advances in surgical techniques and introduction of less-emetogenic anesthetic methods and drugs, postoperative nausea and vomiting, which occurs within 24 hr after surgery, are one of the common and distressing symptoms, following anesthesia and surgery . The frequency of upper and lower gastrointestinal disturbance as a consequence of exercise is reported to be between 30 and 70%, with the severity of symptoms ranging from mild stomach discomfort to severe diarrhea (Ball, Ashley, & Stradling, 2015) . As it is shown in Table 3 , 500 mg ginger per day can reduce postsurgery nausea and vomiting.
Generally, the most common and well-established use of ginger is its utilization in alleviating symptoms of nausea and vomiting (Lete & Allué, 2016) .
Although the included studies generally reported statistically significant reductions in nausea and vomiting measures, the clinical significance of these results was controversial, which could perhaps be explained by the nonstandardized preparations of ginger used and inconsistencies in study methods and outcomes. Multiple potential mechanisms of action have been identified including 5-HT3 receptor antagonism, anti-inflammatory properties, and the modulation of gastrointestinal motility (Marx, Kiss, & Isenring, 2015; Marx et al., 2013) (Table 4 ).
| FAT T Y LIVER
Nonalcoholic fatty liver disease (NAFLD) is one of chronic liver diseases throughout the world that mostly is seen in obese, low active people, and patients with type II diabetes (Ong & Younossi, 2007) .
There is no proven medical treatment for this disorder; however, following a healthy life style, modified diet and exercise are suggested by researchers (Thoma, Day, & Trenell, 2012) . Previous studies have shown that a diet rich in antioxidants and anti-inflammatory agents can be effective in the treatment of NAFLD (Eslamparast, Eghtesad, Poustchi, & Hekmatdoost, 2015) . Rahimlou, Yari, Hekmatdoost, Alavian, & Keshavarz (2016) conducted the first randomized, double-blind clinical trial study that examined the effects of ginger supplementation with lifestyle intervention on liver enzymes, inflammatory markers, steatosis, and hepatic fibrosis scores in patients with nonalcoholic fatty liver disease (NAFLD). In this study, 44 patients with NAFLD consumed 2 g of ginger supplement or placebo per day for 12 weeks. In both groups, patients were advised to follow a balanced diet and physical activity program and resulted in a significant decrease in inflammatory marker levels, liver enzymes, hepatic steatosis, and insulin resistance (that is one of the major risk factors in the pathogenesis of NAFLD) in ginger group. Inflammatory cytokines such as TNF-a play critical role in development of insulin resistance and liver fibrosis and increase fatty acids oxidation. Active compounds in ginger can enhance the antioxidant defense systems such as glutathione peroxidase and glutathione S-transferase, and reduce levels of malondialdehyde (MDA) and hepatic steatosis. Thus, reduction of TNF-α and other inflammatory factors resulted in improvement of the NAFLD characteristics. In this study, no significant decrease was observed in liver fibrosis score in the ginger group compared to the placebo group. This can be due to the short term of the intervention, because it takes a long time for regeneration of hepatic tissue and reduction of fibrotic tissue. Further RCTs are needed to find the mechanism of action and ideal dose of ginger supplementation for NAFLD management. (Basirat, Moghadamnia, Kashifard, & Sarifi-Razavi, 2009; Fischer-Rasmussen, Kjaer, Dahl, & Asping, 1991; Keating & Chez, 2002; Ozgoli, Goli, & Simbar, 2009; Smith, Crowther, Willson, Hotham, & McMillian, 2004; Vutyavanich, Kraisarin, & Ruangsri, 2001) (<1000 mg daily) 250 mg powder (4×) or 4 times/day (3 studies) 350 mg. 3 times/day 250 mg ginger syr. 4 times/day 500 mg ginger biscuit, five times/ day (~2500 mg/day) Placebo (4 days-3 weeks) Ginger was better than placebo in improving nausea when given at a dose of <1000 mg/ day for at least 4 days Viljoen et al. (2014) Meta-analysis of 12 studies 6 additional studies (Chittumma, Kaewkiattikun, & Wiriyasiriwach, 2007; Dante, Pedrielli, Annessi, & Facchinetti, 2013; Ensiyeh & Sakineh, 2009; Mohammadbeigi, Shahgeibi, Soufizadeh, Rezaiie, & Farhadifar, 2011; Pongrojpaw, Somprasit, & Chanthasenanont, 2007; Sripramote & Lekhyananda, 2003) to Thomson et al. (Thomson et al., 2014) . Contains reviews by Dante et al. (2013) , Ding, Leach, & Bradley (2013) 125 mg extract (4×) /day~1000 mg/ day Consumption: 2 × 6 day Evaluation: for 3 × 4-day All concentrations of ginger significantly reduced the incidence of acute, but not delayed nausea, with 0.5 and 1.0 g being the most effective 1.5 g (3 × 500 mg)/day + standard antiemetic regimen
| IRRITAB LE BOWEL SYNDROME (IBS)
Irritable
Standard antiemetic regimen
Consumption: 4 days from the initiation of chemotherapy evaluation: first 6 hr, between 6 and 24 hr, and days 2, 3, and 4 postchemotherapy Reduced nausea 6-24 h postchemotherapy, no other significant additional benefit against prevalence or severity of nausea, vomiting, and retching in any of them during the assessed periods.
1 g ginger (6 × 167 mg) or 2 g (5 × 400 mg) determined by participant's weight 
Experimental RCT 500 mg powdered ginger, mixed with a spoonful of yogurt (×2)/day + standard antiemetic drugs
Standard antiemetic medicines 30 min before chemotherapy for 3 days followed up for 5 days Nausea severity and the number of vomiting episodes were significantly lower in the intervention group than control group, the change in the number of retching episodes was not statistically significant Sanaati et al. (2016) RCT 500 mg (×2) (~1 g/day) of powdered ginger + routine antiemetic regimen 1-Matricaria chamomilla extract + routine antiemetic regimen 2-Control group, routine antiemetic regimen 5 days before and 5 days after chemotherapy Ginger and chamomile were both significantly effective for reducing the frequency of vomiting; ginger significantly influenced the frequency of nausea
RCT crossover 500-mg ginger capsule (×2)/ day (~1 g/day) + anti emetics Placebo+ antiemetics 5 days There were no significant differences between ginger and placebo in nausea severity, vomiting incidence and severity, rescue medication use, chemotherapy compliance, and adverse events. 
RCT 250 mg (×2) ginger powder, (×2)/day (~1 g/day)
Placebo 3 days There were no significant differences between ginger and placebo in nausea and vomiting except in those patients who received the AC regimen chemotherapy, vomiting was less severe comparing to placebo strategies for IBS is limited and about 40% of patients use alternative medicine to treat their symptoms (Van Tilburg et al., 2008 
| G A S TROENTERITIS
Nonsteroid anti-inflammatory drugs (NSAIDs) represent as an important and prevalent medicine with common side effects of gastrointestinal (GI) tract (Solomon & Goodson, 2007) . ( or Diclofenac (a member of NSAIDs) per day for 4 weeks. In this study, ginger group showed significantly lowered gastrointestinal pain and no change in dyspepsia but esophagogastroduodenoscopy showed significantly increased levels of prostaglandins (PGs) PGE1, PGE2, and PGF2a in the stomach mucosa. This rise in gastric mucosa PG levels correlated with an increase in serum gastrin-17, whereas Diclofenac group showed increased gastrointestinal pain and dyspepsia with a corresponding significant decrease in stomach mucosa prostaglandins and general negative stomach mucosa degeneration.
Both groups showed a relevant and significantly lowered arthritic pain, both on standing and moving, so that ginger was as effective as Diclofenac in reducing pain, while it was safer.
| G A S TROINTE S TINAL MALIG NAN CIE S
In a randomized clinical trial, 20 subjects at increased risk for colorectal cancer were assigned to receive either 2 g/day ginger or placebo for 28 days. They showed that ginger was tolerable and safe; however, it did not decrease eicosanoid levels in people at increased risk for colorectal cancer (Zick et al., 2015) . Moreover, Zick et al. reported no significant difference in eicosanoids level in 30 subjects at normal risk for colorectal cancer. However, they found a significant decrease in PGE2 and 5-hydroxyeicosatetraenoicacid (HETE) and a trend toward significant decrease in 12-HETE and 15-HETE normalized to free arachidonic acid (Zick et al., 2011) . In another trial, the effects of ginger (2 g for 28 days) on apoptosis, proliferation, and differentiation in the normal-appearing colonic mucosa from 20 patients at increased risk for colorectal cancer showed that ginger supplementation may reduce proliferation in the crypts of normalappearing colorectal epithelium, increase apoptosis and differentiation relative to proliferation, especially in the differentiation zone of crypts. This beneficial effect of ginger was found to be associated with downregulation of Bax, human telomerase reverse transcriptase (hTERT), and MIB-1, while p21 and Bcl-2 expression remained relatively unchanged. The estimated treatment effect on MIB-1 was not as strong, the estimated effect was more pronounced in the upper sections of the colorectal crypts, suggesting that ginger may decrease proliferation in the parts of the colorectal crypts most exposed to bowel lumen carcinogens (Citronberg et al., 2013) . These findings are consistent with previous studies that suggested that the chemopreventive properties of ginger may be due to regulate cell function and viability (Keum et al., 2002; Lee & Surh, 1998; Miyoshi et al., 2003; Pan et al., 2008) . In vitro and animal studies also suggest that ginger and its constituents may act as chemopreventive agents by reducing COX-2 expression immune function, lowering the activity of microbial enzymes (β-glucuronidase and mucinase), and blocking angiogenic signals that supply blood to tumor cells (Brown et al., 2009; Khater, 2010; Lu et al., 2011; Seo, Lee, & Kim, 2005; Yagihashi, Miura, & Yagasaki, 2008) . Ginger has anti-inflammatory activities that play roles on its chemopreventive potential against colorectal cancer. In a study on 30 normal participants and 20 participants at increased risk for colorectal cancer, ginger significantly lowered COX-1 protein expression in participants at increased risk for colorectal cancer but not in the participants at normal risk.
However, ginger did not alter 15-hydroxyprostaglandin dehydrogenase (PGDH) protein expression in either increased or normal risk participants (Jiang et al., 2013) . Some findings of other studies about beneficial effects of ginger and its constituents in GI cancer patients included: inhibition of COX and decrease in PGE2 concentrations in colorectal cancer (Levine et al., 2008) , reduction in the incidence and multiplicity of adenomas (Zick et al., 2015) , decrease in proliferation (hTERT and MIB-1) and differentiation (p21waf1/cip1) in colonocytes (Stoner, 2013) , inhibition of CYP450, 1-aminobenzotriazole, and aldo-keto reductase in human liver microsomes, prevention of the formation of M14 and M15 and 18β-glycyrrhetinic acid in human liver microsomes (Chen, Soroka, Zhu, & Sang, 2013) .
| DYS PH AG I A
Dysphagia is a major alarm sign in gastroenterology; however, impaired swallowing function from a combination of underlying disease and reduced physical and cognitive abilities could be a result of elderly. This phenomenon and, in particular, dysphagia are associated with reduced cough reflex leading to increased risk of aspiration pneumonia (Hirata et al., 2016) . Furthermore, it may result in malnutrition, dehydration, and decreasing the patient's quality of life.
The swallowing reflex is controlled by substance P (SP) that released by nerve endings in the bronchial mucosa and oral cavity (Jin et al., 1994; Ujiie, Sekizawa, Aikawa, & Sasaki, 1993) . Reduced salivary SP levels in older people are reported to be lower than in healthy younger individuals (Sekizawa, Ujiie, Itabashi, Sasaki, & Takishima, 1990 showed that stimulus on lingua-palatal swallowing pressure and rising and releasing lingua-palatal pressure duration were greater for carbonation + gingerol and carbonation than for water.
| ADVER S E EFFEC TS AF TER ING E S TI ON OF G ING ER
Ginger consumption rarely induces side effects such as mild gastrointestinal complications such as heartburn, belching, bruising or flushing, rash, and gastrointestinal discomfort. Adverse events were generally not significantly higher in the ginger group compared to the control group (Lete & Allué, 2016; Marx et al., 2013) . In a study of 27 healthy volunteers who consumed a single oral dose of 100 mg to 2 g ginger, minor gastrointestinal upset was the major adverse effect (Zick et al., 2009) . Despite previous studies indicating that ginger could interfere with platelet aggregation and cause excessive bleeding (Srivastava, 1986) , a recent crossover study of 12 healthy volunteers who consumed 1.2 g of dried ginger rhizome three times per day for 2 weeks, ginger did not affect platelet aggregation and had no effect on the pharmacokinetics or pharmacodynamics of a single 25 mg dose of warfarin taken on day 7 (Jiang et al., 2005) . Viljoen et al. (2014) also reviewed the safety of ginger as a secondary objective in their meta-analysis of nausea and vomiting of pregnancy and found that ginger did not have a risk for side effects or adverse events during pregnancy. In a prospective study,
Comparator Duration Main results

Placebo standard preoperative antiemetic
Consumption: 1 capsule 30 min before induction of anesthesia and the second 2 hr after surgery evaluation: 0, 2, 2 ½ and 24 hr after surgery
Ginger reduced the number of episodes of intraoperative nausea, but it had no effect on incidence of nausea, vomiting, or pain during and after an elective cesarean section under spinal epidural anesthesia Placebo+ IV Ondansetron (4 mg)
Consumption: 1 hr prior to induction of general anesthesia Evaluation:18 h postoperation Significantly reduced the incidence of postoperative nausea and vomiting compared to ondansetron alone Placebo Consumption:1 hr before surgery, evaluation: 2, 4, 6 hr postoperation
The frequencies of nausea in the experimental group at 2 hr postoperation were borderline significant but no significant differences between two groups in the intensity of vomiting
Half of the subjects in each group received placebo Consumption: Before surgery evaluation : every 15 min for the first 2 postoperative h and the 6th hour
Using ginger essence lowered nausea and vomiting In the first 2 postoperative hours, vs. patients with the same surgery but receiving placebo 30 cc of water Consumption: 1 h before surgery evaluation: 2, 4 hr after surgery
Ginger decreased the incidence and severity of nausea and vomiting during the cesarean section no statistically significant relationship at 2, 4 hr after surgery Placebo Consumption: before operation: 6 AM day of surgery (single dose) or 10 PM (day before and 6 AM day of surgery for 2 dose Evaluation: 6 h after operation
The frequency and intensity of nausea and the frequency of vomiting among those ginger consumers in 2 separate 500 mg doses were less than the one dose and they both were less than placebo Placebo Consumption: 30 min before each dose of antiretroviral Regimen for 14 days
Frequency of mild, moderate, and severe nausea and reported at least one episode of vomiting were significantly lower in the ginger than placebo Placebo Consumption one-half hour before each daily dose of antituberculosis drugs (fasting) for 4 weeks Nausea was more common in the placebo than the ginger group Placebo Consumption: 1 hr before the procedure Evaluation: at 2, 4 and 24 hr after operation
The incidence of the nausea and visual analogue nausea scores was lower in ginger group than placebo at 2 and 4 hr. No difference at 24 hr was found in both groups. Incidence and frequency of vomiting between 2 groups were not statistically different Placebo Consumption: 1 h before the procedure Evaluation: at 2 and 6 h after operation.
At 6 h postoperation, ginger lowered nausea and borderline vomiting but at 2 hr, differences between the two groups for nausea and vomiting were not significant the pregnancy outcome of 187 women who were exposed to ginger during the first trimester of pregnancy was compared with women who had been exposed to non-teratogenic drugs that were not antiemetic. There were no statistically significant differences between the two groups in terms of live births spontaneous abortions, therapeutic abortions, birth weight, or gestational age (Portnoi et al., 2003) . A larger population-based cohort study in Norway (68, 522 women) showed that the use of ginger during pregnancy (1020 women, 1.5%) was not associated with an increased risk of congenital malformations, still birth/perinatal birth, low birth weight, or preterm birth (Heitmann, Nordeng, & Holst, 2013) .
| CON CLUS ION
Based on evidence from this systematic review, ginger could be con- 
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